AZN Preview Mode — Vezi un preview — analiza completa cu Strategy Signals, Smart Money 13F si Insider Trades disponibila cu cont. Sign Up Free → sau Login
📡 SignalRadar — RadarScope
AstraZeneca PLC
AZN NYSE Healthcare Drug Manufacturers - General
$189.62
1M: +5.5% | 3M: -3.9%
Calitate
Q9
Risc
R3
Scor AI
50
Verdict
TINE
Market Cap
$294.1B
P/E Ratio
27.7
Profit Margin
17.2%
ROE
22.4%
📈 Earnings Report — 2026-04
Ultimul trimestru raportat
EPS Actual
$2.58
▲ 21.7% QoQ▲ 4.0% YoY
EPS Estimat
$2.57
Beat by 0.4%
Revenue Actual
$15.29B
▼ 1.4% QoQ▲ 12.5% YoY
Revenue Estimat
$14.93B
Beat by 2.4%
Istoric Ultimele 4 Trimestre
2026-04
EPS Actual
$2.58
EPS Est.
$2.57
Revenue
$15.29B
Beat/Miss
Beat by 0.4%
2026-02
EPS Actual
$2.12
EPS Est.
$2.18
Revenue
$15.50B
Beat/Miss
Miss by 2.8%
2025-11
EPS Actual
$2.38
EPS Est.
$2.29
Revenue
$15.19B
Beat/Miss
Beat by 3.9%
2025-07
EPS Actual
$2.18
EPS Est.
$2.16
Revenue
$14.46B
Beat/Miss
Beat by 0.9%
Urmatorul Raport
Data
2026-07-27
EPS Estimat
$2.1
Revenue Estimat
$15.47B
💰 Dividende Recente
2026-02
$2.17
Yield: 156.71%
Plata: 2026-03
2025-08
$0.515
Yield: 222.76%
Plata: 2025-09
2025-02
$1.05
Yield: 218.89%
Plata: 2025-03
2024-08
$0.5
Yield: 182.9%
Plata: 2024-09
📊 Scoruri Companie
Crestere 9/10
9
Revenue & Profit Growth
Evaluare 5/10
5
P/E · P/B · P/S
Calitate 9/10
9
Marje · ROE · Datorii
Risc 3/10
3
Beta · Market Cap
📈 Date Financiare Istorice in miliarde USD
💰 Revenue
📊 Net Profit
💵 Cash Flow
Operating (albastru) · Free (violet)
🏦 Cash & Datorii
Cash (verde) · Long-term Debt (rosu)
💸 Operating Expenses
🤖 Analiza RadarScope AI
Analiza indisponibila temporar.
💡 Vezi datele de mai jos
🐂 BULL CASE
Date financiare solide
Pozitie competitiva puternica
🐻 BEAR CASE
Evaluare ridicata
Incertitudine macro
TINE Analiza manuala recomandata
📊 Metrici Fundamentale
P/E TTM27.7
P/B TTM6.10
P/S TTM4.75
EV/EBITDA
Gross Margin79.7%
Operating Margin23.5%
Net Margin17.2%
ROE22.4%
ROA9.2%
Debt/Equity
Current Ratio0.91
FCF Yield2.7%
Dividend Yield1.7%
Beta0.21
💰 Venituri & Profit (ultimele trimestre)
TrimestruRevenueGross ProfitNet IncomeEPS
2025-12$58.7B$48.1B$10.3B$6.60
2024-12$54.1B$43.9B$7.0B$2.27
2023-12$45.8B$37.5B$6.0B$3.81
2022-12$44.4B$32.0B$3.3B$2.12
🏢 Profil Companie
CEOPascal Claude Roland Soriot
Angajati94300
IPO1993-05-12
52W High$212.71
52W Low$137.22
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19...
🎯 Score Breakdown
Calitate Companie (Q) 9/10
Risc Speculativ (R) 3/10
Scor AI RadarScope 50/100
VERDICT FINAL
TINE
Analiza manuala recomandata
🤖 Chat AI — Intreaba despre AZN
RadarScope AI
Buna! Pot raspunde la orice intrebare despre AZN. Ce vrei sa stii?

🔒 Analiza completa disponibila cu cont SignalRadar

Vezi Strategy Signals AI (Triple Oversold, BB Squeeze), Smart Money 13F ($837 mld Berkshire+BlackRock+Vanguard), Insider Trades live SEC Form 4, News + Short Interest in timp real, 20+ indicatori tehnici Multi-TF.

🚀 Cont Gratuit (25 tickere) Vezi planurile platite (de la $4.99)
+ 13F Smart Money+ Form 4 Insider+ TA MEGA 20+ indicatori+ AI Signals Triple Oversold etc.+ Multi-TF 1D/1W/1M
[!] Datele sunt informative. NU constituie sfat investitional personalizat. Decizia de investitie iti apartine. Detalii